A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)
- Status
- COMPLETED
- Phase
- PHASE2
Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods
- Status
- COMPLETED
- Phase
- N/A
TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors
- Status
- COMPLETED
- Phase
- PHASE2
Removal of Doravirine by Hemodialysis in HIV-Infected Patients With End-stage Renal Disease (ESRD)
- Status
- COMPLETED
- Phase
- PHASE4
Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)
- Status
- TERMINATED
- Phase
- PHASE1
HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Investigate the Influence of Hepatic Impairment on Elpipodect (MK-8189) Treatment (MK-8189-012)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) [MK-7902-007/E7080-G000-314/LEAP-007] - China Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™
- Status
- TERMINATED
- Phase
- PHASE4
Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE4
Changes in the Prevalence of Oncogenic HPV Types
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa
- Status
- COMPLETED
- Phase
- PHASE4